MA27539A1 - Nouvelle combinaison synergique contenant du roflumilast et du formoterol - Google Patents

Nouvelle combinaison synergique contenant du roflumilast et du formoterol

Info

Publication number
MA27539A1
MA27539A1 MA28343A MA28343A MA27539A1 MA 27539 A1 MA27539 A1 MA 27539A1 MA 28343 A MA28343 A MA 28343A MA 28343 A MA28343 A MA 28343A MA 27539 A1 MA27539 A1 MA 27539A1
Authority
MA
Morocco
Prior art keywords
formoterol
synergistic combination
combination containing
new synergistic
containing roflumilast
Prior art date
Application number
MA28343A
Other languages
English (en)
French (fr)
Inventor
Rolf Beume
Daniela Bundschuh
Norbert Kolassa
Degenhard Marx
Christian Weimar
Original Assignee
Altana Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altana Pharma Ag filed Critical Altana Pharma Ag
Publication of MA27539A1 publication Critical patent/MA27539A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
MA28343A 2002-11-27 2005-06-16 Nouvelle combinaison synergique contenant du roflumilast et du formoterol MA27539A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02026505 2002-11-27

Publications (1)

Publication Number Publication Date
MA27539A1 true MA27539A1 (fr) 2005-09-01

Family

ID=32338002

Family Applications (1)

Application Number Title Priority Date Filing Date
MA28343A MA27539A1 (fr) 2002-11-27 2005-06-16 Nouvelle combinaison synergique contenant du roflumilast et du formoterol

Country Status (31)

Country Link
US (1) US20060142308A1 (enExample)
EP (1) EP1567139B1 (enExample)
JP (1) JP2006508994A (enExample)
KR (1) KR101071798B1 (enExample)
CN (1) CN100346777C (enExample)
AT (1) ATE399543T1 (enExample)
AU (1) AU2003292120B2 (enExample)
BR (1) BR0316451A (enExample)
CA (1) CA2506962C (enExample)
CO (1) CO5690570A2 (enExample)
CY (1) CY1110369T1 (enExample)
DE (1) DE60321953D1 (enExample)
DK (1) DK1567139T3 (enExample)
EA (1) EA009935B1 (enExample)
ES (1) ES2309357T3 (enExample)
HR (1) HRP20050579B1 (enExample)
IL (1) IL168308A (enExample)
IS (1) IS2575B (enExample)
MA (1) MA27539A1 (enExample)
ME (1) ME00489B (enExample)
MX (1) MXPA05005437A (enExample)
NO (1) NO334247B1 (enExample)
NZ (1) NZ540659A (enExample)
PL (1) PL216752B1 (enExample)
PT (1) PT1567139E (enExample)
RS (1) RS51081B (enExample)
SI (1) SI1567139T1 (enExample)
TN (1) TNSN05131A1 (enExample)
UA (1) UA83018C2 (enExample)
WO (1) WO2004047829A1 (enExample)
ZA (1) ZA200503308B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
RS52908B (sr) 2003-03-10 2014-02-28 Takeda Gmbh Novi postupak za dobijanje roflumilasta
CA2601250C (en) * 2005-03-16 2014-10-28 Nycomed Gmbh Taste masked dosage form containing roflumilast
DE102005030733A1 (de) * 2005-07-01 2007-01-04 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittelkombinationen zur Behandlung von Atemwegserkrankungen enthaltend langwirksame Beta-2-Agonisten und wenigstens einen weiteren Wirkstoff
ATE535244T1 (de) * 2006-07-05 2011-12-15 Nycomed Gmbh Kombination aus atorvastatin mit einem phosphodiesterase-4-hemmer zur behandlung von entzündlichen lungenerkrankungen
WO2013077830A1 (en) * 2011-11-25 2013-05-30 Mahmut Bilgic Synergistilly active combinations of roflumilast and carmoterol
US20130172303A1 (en) * 2012-01-03 2013-07-04 Forest Laboratories Holdings Ltd. Roflumilast compositions for the treatment of copd
PL2948148T3 (pl) * 2013-01-28 2021-01-25 Incozen Therapeutics Pvt. Ltd. Sposoby leczenia zaburzeń autoimmunologicznych, oddechowych i zapalnych przez wziewne podawanie n-tlenku roflumilastu
CN104800214A (zh) * 2014-01-27 2015-07-29 成都英诺新科技有限公司 一种罗氟司特吸入气雾剂复方及制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5795564A (en) * 1991-04-05 1998-08-18 Sepracor, Inc. Methods and compositions for treating pulmonary disorders using optically pure (R,R)-formoterol
SI0706513T1 (en) * 1993-07-02 2002-10-31 Altana Pharma Ag Fluoroalkoxy-substituted benzamides and their use as cyclic nucleotide phosphodiesterase inhibitors
EA001758B1 (ru) * 1997-02-17 2001-08-27 Бык Гульден Ломберг Хемише Фабрик Гмбх Композиции для лечения респираторного дистресс-синдрома взрослых или респираторного дистресс-синдрома новорожденных, содержащие 3-(циклопропилметокси)-n-(3,5-дихлор-4-пиридинил)-4-(дифторметокси)бензамид и легочное поверхностно-активное вещество
US6624181B1 (en) * 1997-02-28 2003-09-23 Altana Pharma Ag Synergistic combination
JP2001513097A (ja) * 1997-02-28 2001-08-28 ビイク グルデン ロンベルク ヒエーミツシエ フアブリーク ゲゼルシヤフト ミツト ベシユレンクテル ハフツング Ｐｄｅ−抑制物質とアデニル酸シクラーゼ・アゴニストもしくはグアニル酸シクラーゼ・アゴニストとからなる相乗的組み合わせ組成物
CZ293735B6 (cs) * 1998-08-26 2004-07-14 Smithkline Beecham Corporation Farmaceutický prostředek pro léčbu plicní nemoci
US6303145B2 (en) * 1999-05-10 2001-10-16 Sepracor Inc. (S,R) formoterol methods and compositions
SI1212089T1 (sl) * 1999-08-21 2006-08-31 Altana Pharma Ag Sinergisticna kombinacija roflumilasta in salmeterola
GB0103630D0 (en) * 2001-02-14 2001-03-28 Glaxo Group Ltd Chemical compounds
ES2296923T3 (es) * 2001-03-22 2008-05-01 Glaxo Group Limited Derivados formanilidas como agonistas del adrenorreceptor beta2.
ES2314052T3 (es) * 2001-04-30 2009-03-16 Glaxo Group Limited Derivados de ester de 17beta-carbotioato de androstano con un grupo ester ciclico en la posicion 17alfa.

Also Published As

Publication number Publication date
DK1567139T3 (da) 2008-11-03
RS51081B (sr) 2010-10-31
IS2575B (is) 2010-02-15
KR101071798B1 (ko) 2011-10-11
PL216752B1 (pl) 2014-05-30
JP2006508994A (ja) 2006-03-16
ZA200503308B (en) 2006-11-29
ES2309357T3 (es) 2008-12-16
EP1567139B1 (en) 2008-07-02
CO5690570A2 (es) 2006-10-31
CY1110369T1 (el) 2015-04-29
AU2003292120B2 (en) 2010-01-21
CA2506962C (en) 2012-01-03
CA2506962A1 (en) 2004-06-10
CN100346777C (zh) 2007-11-07
IS7898A (is) 2005-06-20
NO20052999L (no) 2005-06-17
AU2003292120A1 (en) 2004-06-18
EA009935B1 (ru) 2008-04-28
ATE399543T1 (de) 2008-07-15
MXPA05005437A (es) 2005-08-03
TNSN05131A1 (en) 2007-05-14
SI1567139T1 (sl) 2008-12-31
DE60321953D1 (de) 2008-08-14
NZ540659A (en) 2007-05-31
EP1567139A1 (en) 2005-08-31
HRP20050579B1 (hr) 2014-01-31
PL377732A1 (pl) 2006-02-06
RS20050382A (sr) 2007-08-03
WO2004047829A8 (en) 2005-06-30
WO2004047829A1 (en) 2004-06-10
HRP20050579A2 (hr) 2006-04-30
US20060142308A1 (en) 2006-06-29
NO334247B1 (no) 2014-01-20
KR20050085104A (ko) 2005-08-29
ME00489B (me) 2011-10-10
PT1567139E (pt) 2008-10-01
IL168308A (en) 2010-12-30
UA83018C2 (uk) 2008-06-10
EA200500774A1 (ru) 2005-12-29
BR0316451A (pt) 2005-10-11
CN1713903A (zh) 2005-12-28
HK1081861A1 (en) 2006-05-26

Similar Documents

Publication Publication Date Title
TNSN07063A1 (fr) Utilisations therapeutiques d'inhibiteurs de rtp801
ATE320800T1 (de) Synergistische kombination von roflumilast und salmeterol
AU2002225772A1 (en) Therapeutic agents and methods of use thereof for treating an amyloidogenic disease
NO20025601D0 (no) Arylmetylaminderivater for anvendelse som tryptaseinhibitorer
MY127980A (en) A pyrrolidineacetamide derivative alone or in combination for treatment of cns disorders
MA27334A1 (fr) Utilisation d'inhibiteurs de l'ikb kinase dans le traitement de la douleur
ATE318601T1 (de) Zusammensetzungen zur behandlung des schnupfens, welche ipratropium und xylometazolin enthalten
GB0012362D0 (en) Chemical compounds
ATE219657T1 (de) Nasale lösungen
MA27539A1 (fr) Nouvelle combinaison synergique contenant du roflumilast et du formoterol
MXPA05009986A (es) Tratamiento de la enfermedad de alzheimer.
UA42719C2 (uk) Сполуки, композиції та способи, які інгібують протеази, для лікування та профілактики імуномедіаторних запальних хвороб
ATE311928T1 (de) (-)-pseudoephedrin als sympathomimetisches arzneimittel
DK1656131T3 (da) Anvendelse af betain til behandling claudicatio intermittens
BR9915123A (pt) Composição de uma substância farmaceuticamente ativa e dispensador
MXPA04002560A (es) Combinacion de un nsaid y un inhibidor pde-4.
GEP20053512B (en) S-Methyl-Dihydro-Ziprasidone for Treatment of Psychiatric and Ocular Disorders.
EA200500865A1 (ru) Синергетическая комбинация, включающая рофлумиласт и r,r-формотерол
MA28266A1 (fr) Utilisation de l'agomelatine pour l'obtention de medicaments destines au traitement des troubles bipolaires
MD2875F1 (en) Remedy for nasal congestion treatment
DE60126504D1 (de) Verwendung von gegen candida wirksamen mitteln zur behandlung von störungen der oralen und intestinalen mucosa
TNSN01081A1 (fr) Compositions de s-methyl-dihydro-ziprasidone